Breast Cancer Episode 20: Primary results from the TROPION-Breast01 study on Dato-DXd in HR+/HER2- metastatic breast cancer treatment 21 March 2024
GI Episode 11: Sotorasib plus panitumumab increases PFS in metastatic KRAS G12C mutated colorectal cancer patients: CodeBreak 300 20 March 2024
Lung Cancer Episode 8: The LIBRETTO-431 trial demonstrates the efficacy of selpercatinib in RET fusion-positive NSCLC 19 March 2024
GUUrothelial cancer Episode 9: Double ADC treatment as a promising approach in mUC: a dose-response trial 18 March 2024
Breast Cancer Episode 19: Efficacy of ADC therapy in HER2 low breast cancer: updated results from DESTINY-Breast04 14 March 2024
GI Episode 10: MOUNTAINEER-02 introducing TUC with Tras as a new standard for HER2+ RAS WT mCRC patients 13 March 2024
Lung Cancer Episode 7: AEGEAN study results confirm ctDNA as a predictive biomarker for pCR in NSCLC patients with neoadjuvant treatment 12 March 2024
GURenal cancer Episode 8: Rechallenging with immune checkpoint inhibitors does not benefit mRCC patients after progression 11 March 2024
Breast Cancer Episode 18: Olaparib increases ORR in advanced cancers with BRCA1/2 but not CHEK2 and ATM mutations, the PRECISION 2 trial 7 March 2024
GI Episode 9: First data from CheckMate 8WH investigating double immunotherapy as a first line treatment in MSI-H/dMMR metastatic colon cancer 6 March 2024
